miR‐200a‐3p inhibits the PDGF‐BB‐induced proliferation of VSMCs by affecting their phenotype‐associated proteins
Journal of Biochemical and Molecular Toxicology · 2024
DOI: 10.1002/jbt.23675 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2024. Verfasst von Rui-Yuan Zeng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: Muscle, Smooth, Vascular, MicroRNAs. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province, Key Research and Development Program of Jiangxi Province.
Abstract (Originalsprache)
Accumulating evidence shows that the abnormal proliferation and migration of vascular smooth muscle cells (VSMCs) can significantly affect the long‐term prognosis of coronary artery bypass grafting. This study aimed to explore the factors affecting the proliferation, migration, and phenotypic transformation of VSMCs. First, we stimulated VSMCs with different platelet‐derived growth factor‐BB (PDGF‐BB) concentrations, analyzed the expression of phenotype‐associated proteins by Western blotting, and examined cell proliferation by scratch wound healing and the 5‐ethynyl‐2‐deoxyuridine (EdU) assay. VSMC proliferation was induced most by PDGF‐BB treatment at 20 ng/mL. miR‐200a‐3p decreased significantly in A7r5 cells stimulated with PDGF‐BB. The overexpression of miR‐200a‐3p reversed the downregulation of α‐SMA ( p < 0.001) and the upregulation of vimentin ( p < 0.001) caused by PDGF‐BB. CCK8 and EdU analyses showed that miR‐200a‐3p overexpression could inhibit PDGF‐BB‐induced cell proliferation ( p < 0.001). However, flow cytometric analysis showed that it did not significantly increase cell apoptosis. Collectively, the overexpression of miR‐200a‐3p inhibited the proliferation and migration of VSMCs induced by PDGF‐BB, partly by affecting phenotypic transformation‐related proteins, providing a new strategy for relieving the restenosis of vein grafts.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
- Institute of Cardiovascular Surgical Diseases, Jiangxi Academy of Clinical Medical Sciences, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi, China.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Key Research and Development Program of Jiangxi Province
- Health Commission of Jiangxi Province
Zitieren
APA
Zeng, R. Y., Jin, H. Y., Peng, Y. B., Wang, W. J., Cao, Y. P., Peng, H. Z., Qiu, Z. C., Lai, S. Q., & Wan, L. (2024). miR‐200a‐3p inhibits the PDGF‐BB‐induced proliferation of VSMCs by affecting their phenotype‐associated proteins. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.23675
Vancouver
Zeng RY, Jin HY, Peng YB, Wang WJ, Cao YP, Peng HZ, et al. miR‐200a‐3p inhibits the PDGF‐BB‐induced proliferation of VSMCs by affecting their phenotype‐associated proteins. Journal of Biochemical and Molecular Toxicology. 2024. doi:10.1002/jbt.23675
BibTeX
@article{Zeng2024,
author = {Zeng, Rui-Yuan and Jin, Hong-Yi and Peng, Yong-Bo and Wang, Wen-Jun and Cao, Yuan-Ping and Peng, Han-Zhi and Qiu, Zhi-Cong and Lai, Song-Qing and Wan, Li},
title = {miR‐200a‐3p inhibits the PDGF‐BB‐induced proliferation of VSMCs by affecting their phenotype‐associated proteins},
journal = {Journal of Biochemical and Molecular Toxicology},
year = {2024},
doi = {10.1002/jbt.23675}
}
EUVIMED